Literature DB >> 934784

Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings.

J C Dobson, E Kushida, M Williamson, E G Friedman.   

Abstract

Thirty-six patients with a confirmed diagnosis of phenylketonuria (PKU) were identified and placed on dietary therapy before reaching 121 days of age. These children are currently between 4 and 6 years old, and have been given the Stanford-Binet Intelligence Scale. Subsequently, their normal siblings of closet age were selected as matched-pair controls and were also tested with the Stanford-Binet. The mean age of the PKU sample when tested was 50.0 months, and 50.9 months for the normal controls. The 36 index patients scored a mean IQ of 94 and their nonaffected siblings obtained a mean IQ of 99. This five-point mean difference was significant at the .02 level, and suggests the presence of a minimal intellectual impairment associated with PKU, even when treatment begins early and is rigorously monitored.

Entities:  

Mesh:

Year:  1976        PMID: 934784

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats.

Authors:  Simone Luisa Berti; Guilherme Marmontel Nasi; Cristina Garcia; Fernanda Luz de Castro; Michely Lopes Nunes; Denise Bertin Rojas; Tarsila Barros Moraes; Carlos Severo Dutra-Filho; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2011-11-19       Impact factor: 3.584

2.  Influence of the phenylketonuric heterozygote on the developing fetus.

Authors:  B Cabalska; I Miesowicz; K Zorska; I Nowaczewska; N Duczynska
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

3.  Phenylketonuric patients decades after diet.

Authors:  R O Fisch; P N Chang; S Weisberg; P Guldberg; F Güttler; M Y Tsai
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age.

Authors:  R Koch; C Azen; E G Friedman; M L Williamson
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

6.  Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.

Authors:  I Smith; M E Lobascher; J E Stevenson; O H Wolff; H Schmidt; S Grubel-Kaiser; H Bickel
Journal:  Br Med J       Date:  1978-09-09

Review 7.  Diseases of phenylalanine metabolism.

Authors:  C E Parker
Journal:  West J Med       Date:  1979-10

8.  Personality disorder in young women with treated phenylketonuria.

Authors:  S E Waisbren; J Zaff
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Executive function impairment in early-treated PKU subjects with normal mental development.

Authors:  V Leuzzi; M Pansini; E Sechi; F Chiarotti; Cl Carducci; G Levi; I Antonozzi
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".

Authors:  C R Scriver; D E Cole; S A Houghton; H L Levy; A Grenier; C Laberge
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.